ADA/CD26 axis increases intra-tumor PD-1⁺CD28⁺CD8⁺ T-cell fitness and affects NSCLC prognosis and response to ICB

Ornella Franzesea Department of Systems Medicine, University of Rome ”Tor Vergata”, Rome, ItalyCorrespondence[email protected]
View further author information

Belinda Palermob Tumor Immunology and Immunotherapy Unit, IRCCS-Regina Elena National Cancer Institute, Rome, ItalyView further author information

Giuseppe Frisullob Tumor Immunology and Immunotherapy Unit, IRCCS-Regina Elena National Cancer Institute, Rome, ItalyView further author information

Mariangela Panettab Tumor Immunology and Immunotherapy Unit, IRCCS-Regina Elena National Cancer Institute, Rome, ItalyView further author information

Giulia Campob Tumor Immunology and Immunotherapy Unit, IRCCS-Regina Elena National Cancer Institute, Rome, ItalyView further author information

Daniel D’Andreac Department of Biosciences, School of Science and Technology, Nottingham Trent University, Nottingham, UKView further author information

Isabella Sperdutid Biostatistics and Scientific Direction, IRCCS-Regina Elena National Cancer Institute, Rome, ItalyView further author information

Riccardo Tajee Thoracic-Surgery Unit, IRCCS-Regina Elena National Cancer Institute, Rome, ItalyView further author information

Paolo Viscaf Pathological Anatomy Unit, IRCCS-Regina Elena National Cancer Institute, Rome, ItalyView further author information

Paola Nisticòb Tumor Immunology and Immunotherapy Unit, IRCCS-Regina Elena National Cancer Institute, Rome, ItalyCorrespondence[email protected]

Your download is now in progress and you may close this window